The use of a proposed updated EARL harmonization of 18F-FDG PET-CT in patients with lymphoma yields significant differences in Deauville score compared with current EARL recommendations
Abstract Background The Deauville score (DS) is a clinical tool, based on the comparison between lesion and reference organ uptake of 18F-fluorodeoxyglucose (FDG), used to stratify patients with lymphoma into categories reflecting their disease status. With a plethora of positron emission tomography...
Main Authors: | John Ly, David Minarik, Lars Edenbrandt, Per Wollmer, Elin Trägårdh |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2019-07-01
|
Series: | EJNMMI Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13550-019-0536-3 |
Similar Items
-
The effect of reduced scan time on response assessment FDG-PET/CT imaging using Deauville score in patients with lymphoma
by: Charlotte Hornnes, et al.
Published: (2021-01-01) -
Sarcoid-Like Reaction in Non-Hodgkin’s Lymphoma—A Diagnostic Challenge for Deauville Scoring on <sup>18</sup>F-FDG PET/CT Imaging
by: Michael Winkelmann, et al.
Published: (2021-05-01) -
Quantitative implications of the updated EARL 2019 PET–CT performance standards
by: Andres Kaalep, et al.
Published: (2019-12-01) -
SUV variability in EARL-accredited conventional and digital PET
by: Daniëlle Koopman, et al.
Published: (2019-12-01) -
The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma
by: Yi Wen Mo, et al.
Published: (2021-04-01)